MYOCENE
Improving athelte's performance thanks to objective muscle fatigue measurement
Improving athelte's performance thanks to objective muscle fatigue measurement
Myocene® is a Liège-based life science company, active in sports and medicine, which creates unique and innovative devices for measuring muscle fatigue and performance. Thanks to patented algorithms and AI, the Myocene very accurate measurement of muscle performance and fatigue is a breakthrough for athletes. The company, founded in 2020, has received a recent €524.07KConvertible Note investment on 15 March 2023, with investments from Noshaq, WING by Digital Wallonia, and Pierre Rigaux. With their slogan "Improving athlete's performance thanks to objective muscle fatigue measurement", Myocene is poised to make a significant impact in the sports and medical industries within Belgium.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €3.00M | 3 |
|
18 Jun 2024 |
| Convertible Note | Unknown | - | 18 Jun 2024 | |
| Convertible Note | €524.07K | 3 |
|
15 Mar 2023 |
| Debt Financing | €350.00K | 1 | SOWALFIN | 15 Mar 2023 |
| Seed Round | €525.00K | 3 |
|
15 Mar 2023 |
No recent news or press coverage available for MYOCENE.
We care about your data, and we'd love to use cookies make your experience better.
